​The US Food & Drug Administration (FDA) will host its annual Regulatory Education for Industry (REdI) Conference as a virtual no-cost event, June 5-9.

This is an excellent learning opportunity for industry professionals to hear directly from FDA’s experts in drugs, medical devices, & biologics, on the latest activities in regulatory requirements and to build upon their regulatory knowledge.

Conference topics that you may not want to miss include sessions that cover human factors reviews and the 510(k) submission process, such as:

  • Day Two (June 6) (CDER Session): Use-Related Risk Analysis (URRA) and Human Factor (HF) Protocol Reviews: What to Submit for an Efficient Review

  • Day Three (June 7) (CDRH Session): Detangling the 510(k) Process


To learn more and to register, visit: https://www.fda.gov/drugs/news-events-human-drugs/regulatory-education-industry-redi-annual-conference-2023-06052023